251 related articles for article (PubMed ID: 12056719)
1. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
Taylor PM; Allen SP; Dreger SA; Yacoub MH
J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
[TBL] [Abstract][Full Text] [Related]
2. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping.
Taylor PM; Sachlos E; Dreger SA; Chester AH; Czernuszka JT; Yacoub MH
Biomaterials; 2006 May; 27(13):2733-7. PubMed ID: 16406000
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
Appleton AJ; Appleton CT; Boughner DR; Rogers KA
Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
[TBL] [Abstract][Full Text] [Related]
5. Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells.
Latif N; Sarathchandra P; Thomas PS; Antoniw J; Batten P; Chester AH; Taylor PM; Yacoub MH
J Heart Valve Dis; 2007 Jan; 16(1):56-66. PubMed ID: 17315384
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin.
Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2000 Jan; 9(1):150-8. PubMed ID: 10678389
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
8. Potential for synthesis and degradation of extracellular matrix proteins by valve interstitial cells seeded onto collagen scaffolds.
Dreger SA; Thomas P; Sachlos E; Chester AH; Czernuszka JT; Taylor PM; Yacoub MH
Tissue Eng; 2006 Sep; 12(9):2533-40. PubMed ID: 16995786
[TBL] [Abstract][Full Text] [Related]
9. Force generation of different human cardiac valve interstitial cells: relevance to individual valve function and tissue engineering.
Smith S; Taylor PM; Chester AH; Allen SP; Dreger SA; Eastwood M; Yacoub MH
J Heart Valve Dis; 2007 Jul; 16(4):440-6. PubMed ID: 17702371
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
[TBL] [Abstract][Full Text] [Related]
11. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
12. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
13. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
Rabkin-Aikawa E; Farber M; Aikawa M; Schoen FJ
J Heart Valve Dis; 2004 Sep; 13(5):841-7. PubMed ID: 15473488
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
16. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
17. Molecules mediating cell-ECM and cell-cell communication in human heart valves.
Latif N; Sarathchandra P; Taylor PM; Antoniw J; Yacoub MH
Cell Biochem Biophys; 2005; 43(2):275-87. PubMed ID: 16049351
[TBL] [Abstract][Full Text] [Related]
18. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE
Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739
[TBL] [Abstract][Full Text] [Related]
19. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
[TBL] [Abstract][Full Text] [Related]
20. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering.
Aikawa E; Whittaker P; Farber M; Mendelson K; Padera RF; Aikawa M; Schoen FJ
Circulation; 2006 Mar; 113(10):1344-52. PubMed ID: 16534030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
